Product Program year 2022 Source: CMS Open Payments

Crosser iQ

Device BD Interventional Peripheral Intervention

PDI 00801741201332

Open in the dashboard

General payments

$5,866

140 payments

Research payments

$0

0 payments

Through program year 2022, $5,866 in general payments and $0 in research payments were reported against Crosser iQ (BD Interventional Peripheral Intervention).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2022 General $5,866 140

Breakdown

Who paid General payments · program year 2022
  1. Bard Peripheral Vascular, Inc. $5,750 139 payments
  2. Becton, Dickinson and Company $116 1 payment
Top recipients General payments · program year 2022
  1. Ian Cawich Cardiovascular Disease · Little Rock, AR $1,014 17% · 8 payments
  2. John Dussel Vascular Surgery · Wilsonville, OR $392 7% · 1 payment
  3. John Park Vascular Surgery · Omaha, NE $214 4% · 4 payments
  4. Karthikeshwar Kasirajan Vascular Surgery · Palo Alto, CA $159 3% · 4 payments
  5. Ehrin Armstrong Interventional Cardiology · Englewood, CO $158 3% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Vascular Surgery Surgery $2,561 44% · 43 practitioners
  2. Cardiovascular Disease Internal Medicine $1,318 22% · 11 practitioners
  3. Interventional Cardiology Internal Medicine $625 11% · 12 practitioners
  4. Surgery $262 4% · 7 practitioners
  5. Physician Assistant, Medical Physician Assistant $229 4% · 4 practitioners

The top 5 of 16 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. California $1,117 19% · 17 recipients
  2. Arkansas $1,050 18% · 2 recipients
  3. Texas $508 9% · 12 recipients
  4. Oregon $392 7% · 1 recipient
  5. Nebraska $339 6% · 6 recipients

The top 5 of 29 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

140 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record